Toyo Suisan Kaisha, Ltd.

Gunma University

M.t.3, Inc.

Oki Electric Industry Co., Ltd.

Fumio Sugawara

Kengo Sakaguchi

Kazuyoshi Masaki

Takayuki Yamazaki

Keisuke Ohta

Kotaro Nakayama

Noriyuki Sato

Hiroeki Sahara

Tatsuya Fujita

Shinji Katsura

Hiroaki Horiuchi

Ichiro Matsuo

Masahiko Oshige

Tsutomu Yoshida

Toshitada Yoshihara

Seiji Tobita

Tetsuo Okutsu

Hiroshi Murata

Yoko Mori

Nobuaki Takahashi

Masahiko Miura

Masahiro Ishima

Kiyoshige Hatta

Manabu Shimojoe

Noriko Asano

Mika Takenouchi

There is provided with a porphyrin compound represented by Formula (I) or a salt thereof; 

Porphyrin compound or salt thereof, cancer therapeutic agent, photosensitizer, and fluorescent probe

There is provided with a compound. The compound is represented by formula or a salt thereof. Ris an aliphatic hydrocarbon group having 10 to 26 carbon atoms.

Compound or salt thereof

Sulfoquinovosylacyl propanediol compounds represented by formula (I): wherein Ris an acyl residue of a fatty acid, Y is a number of 1, 2 or 3, and M represents a cation having a positive charge equal to Y and pharmaceutically acceptable salts thereof are effective for treating tumors.

Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same

A method for treating an adenocarcinoma excluding colon cancer, lung cancer and gastric cancer, comprising administering to a subject in need thereof and suffering from adenocarcinoma cancer, a pharmaceutically effective amount of at least one sulfoquinovosylacylglycerol compound represented by formula (1): wherein Rrepresents an acyl residue of an unsaturated higher fatty acid, and Rrepresents a hydrogen atom, and/or at least one pharmaceutically acceptable salt thereof.

Method for treating cancer

Peptides having, as constitutive amino acids, (1) 4 glutamine residues, 1 glutamic acid residue, 1 serine residue, 2 valine residues, 1 isoleucine residue and 5 leucine residues, and having a 3-hydroxydecanoyl group bonded, via an amide linkage, to the N-terminal leucine residue thereof; (2) 4 glutamine residues, 1 glutamic acid residue, 1 serine residue, 3 valine residues, and 5 leucine residues, and having a 3-hydroxydecanoyl group bonded, via an amide linkage, to the N-terminal leucine residue thereof; or (3) 4 glutamine residues, 1 glutamic acid residue, 1 serine residue, 2 valine residues, 1 isoleucine residue and 5 leucine residues, and having a 3-hydroxydodec-5-enoyl group bonded, via an amide linkage, to the N-terminal leucine residue thereof. The peptides have an antiviral activity. A strain capable of producing the above peptides and belonging to a new species of genus

Peptides, derivates thereof, process for producing the same, novel strain producing the same, and antiviral agent comprising the same as active ingredient

A method for treating a cancer. The cancer excluding an adenocarcinoma and being epithelioma, glioma, sarcoma, melanoma, lymphoma or leukemia; or the cancer is an adenocarcinoma cancer excluding colon cancer, lung cancer and gastric cancer. The method comprises administering to a subject in need thereof and suffering from cancer, a pharmaceutically effective amount of at least one sulfoquinovosylacylglycerol compound represented by formula (1): wherein Rrepresents an acyl residue of an unsaturated fatty acid and Rrepresents a hydrogen atom and/or at least one pharmaceutically acceptable salt thereof.

An immunosuppressive agent comprising, as an effective ingredient, at least one compound selected from the group consisting of compounds represented by general formula (1) below and pharmaceutically acceptable salts thereof:wherein Rrepresents an acyl residue of a higher fatty acid, and Rrepresents a hydrogen atom or acyl residue of a higher fatty acid.

Immunosuppressive agent

Administration of a sulfopyranosylacylglycerol to treat certain cancers

Sulforhamnosylacyglycerol derivatives and use thereof as medicaments

Sulfofucosylacylglycerol derivatives and administration thereof as medicaments

Method of treating cancer

Method of treating gastric or colon cancer by administration of a sulfoquinovosylacylglycerol ester

Sulfoquinovosylacylglycerol derivative, and use thereof as medicaments

1-0-(2-propenyl)-6-0-sulfonylpyranosides

1-O-(2-propenyl)-6-deoxy-6-carbonylthiopyranosides

Growing community of inventors

Niiza, Japan

Fumio Sugawara